Consuming large amounts of daily caffeine may increase the risk of glaucoma more than three-fold for those with a genetic predisposition to higher eye pressure according to an international, multi-center study. The research ...
Jun 7, 2021
0
162
Glaucoma involves a high risk of losing sight. Researchers at Karolinska Institutet and St. Erik Eye Hospital, among others, have now studied the effects of nicotinamide, the amide of vitamin B₃, on animal and cell models ...
May 17, 2021
1
393
Glaucoma is a group of eye diseases wherein increased pressure within the eye can, if left untreated, lead to damage to the optic nerve and vision loss. Its detection relies on measuring intraocular pressure, visual examination ...
May 14, 2021
0
3
More than 20 years after the launch of a landmark clinical trial, follow-up examinations and analyses found that not all patients with elevated eye pressure need pressure-lowering treatment to prevent vision loss from glaucoma.
Apr 15, 2021
0
0
A chemical known to protect nerve cells also slows glaucoma, the leading cause of irreversible blindness, results of a new study in rats show.
Apr 14, 2021
0
180
A type of glaucoma called normal-tension glaucoma is associated with an increased risk of cognitive impairment and possibly dementia, finds research published online in the British Journal of Ophthalmology.
Mar 29, 2021
0
47
Researchers from City, University London, supported by Allergan Pharmaceuticals and Glaucoma UK, have today released the latest edition of an app to help people newly diagnosed with glaucoma.
Mar 8, 2021
0
2
Smartphones could be used to scan people's eyes for early-warning signs of glaucoma—helping to prevent severe ocular diseases and blindness, a new study reveals.
Feb 25, 2021
0
3
In the largest genome-wide association study of glaucoma comparing the genes of 34,179 people with the disease to 349,321 control subjects, an international consortium of researchers identified 44 new gene loci and confirmed ...
Feb 24, 2021
0
75
Scientists at the University of Birmingham, UK, have shown that a novel low molecular weight dextran-sulphate, ILB could play a key role in treating open angle glaucoma (OAG), a neurodegenerative disease that affects over ...
Jan 7, 2021
0
121
